BioPharma APAC - Leading Source of Biopharmaceutical Intelligence in Asia Pacific

BioPharma Pharma Research

Cancer Research UK Funded Trial Finds that Chemotherapy Before Surgery Cuts the Risk of Colon Cancer from Returning

Led by the University of Birmingham and the University of Leeds, the Cancer Research UK-funded FOxTROT trial found that giving colon cancer patients c...

March 22, 2023 | News

Aptamer launches Optimer®-Fc as a new reagent solution for immunohistochemistry

Two top 10 pharma companies are seeking to trial Optimer-Fc for IHC Aptamer is currently working with one of the top three IHC companies to validate the...

March 21, 2023 | News

Cleveland Clinic and IBM Unveil First Quantum Computer Dedicated to Healthcare Research

Cleveland Clinic and IBM (NYSE: IBM) officially unveiled the first deployment of an onsite private sector IBM-managed quantum computer in th...

March 21, 2023 | News

BioNTech and OncoC4 to Co-Develop and Commercialize Novel Checkpoint Antibody for Solid Tumor Treatment

BioNTech SE (Nasdaq: BNTX, “BioNTech”) and OncoC4, Inc. (“OncoC4”), a clinical-stage biopharmaceutical company dedicated...

March 20, 2023 | News

Etana has secured financing from Deg, East Ventures and other global investors

Etana is committed to build production capacity for mammalian cell for monoclonal antibodies drug substance to ensure high local content production a...

March 20, 2023 | News

Aitia and UCB Announce Strategic Drug Discovery Collaboration in Huntington's Disease

Huntington's disease is a debilitating genetic disorder that affects the brain, causing gradual degeneration of nerve cells in specific areas of the brain,...

March 20, 2023 | News

Connect Biopharma's CBP-201 demonstrates swift relief of Atopic Dermatitis symptoms in pivotal study in China

Stage 1 of ongoing 52-week China pivotal AD trial met primary and secondary endpoints No efficacy plateau at Week 16 In the study “CBP-201, a n...

March 20, 2023 | News

RVAC Medicines announces research collaboration with University of Pennsylvania mRNA Vaccine Pioneer

Autoimmune diseases occur when the body's immune system becomes oversensitive to proteins that are normally harmless, thus triggering a reaction that leads...

March 18, 2023 | News

Servier's Phase 3 INDIGO trial shows positive results for vorasidenib in IDH-mutant Glioma

Clinically meaningful achievement of primary and secondary endpoints is first major advance in treatment of low-grade glioma in more than 20 years Endpo...

March 15, 2023 | News

Improving Drug Safety and Regulatory Compliance: How AI is Revolutionizing Quality Control in Pharma Manufacturing

Quality control is an essential aspect of pharmaceutical manufacturing that ensures drugs are safe, effective, and meet regulatory standards. However, trad...

March 10, 2023 | Opinion

NCODA International Executive Council to Advance Medically Integrated Oncology Worldwide

NCODA is a leading non-profit organization (NY, USA) dedicated to improving the quality of cancer care and promoting the highest standards in the field of ...

March 10, 2023 | News

Alnylam and Medison Pharma expand RNAi Therapeutics Partnership

Alnylam Pharmaceuticals, Inc. (Nasdaq: ALNY), the leading RNAi therapeutics company, and Medison Pharma ("Medison"), a global pharma co...

March 09, 2023 | News

IIVS and Toxys Enter into Agreement to Offer ToxTracker® for In Vitro Genetic Toxicity Evaluation

The Institute for In Vitro Sciences (IIVS) and Toxys have entered into a license agreement that allows IIVS to offer the ToxTracker®...

March 09, 2023 | News

Estrella Biopharma's ARTEMIS® T Cell Therapy EB103 IND Cleared by FDA for B-Cell Lymphomas Clinical Trial

Estrella Biopharma, Inc. ("Estrella"), a biopharmaceutical company whose mission is to harness the evolutionary power of the human immune system to transfo...

March 09, 2023 | News

Stay Connected